National Institute of Biomedical Genomics, Kalyani, West Bengal, India.
Indian Institute of Technology-Jodhpur, Jodhpur, India(1).
Gene. 2022 Apr 20;819:146259. doi: 10.1016/j.gene.2022.146259. Epub 2022 Feb 1.
Pancreatic ductal adenocarcinoma (PDAC) has a strong genetic component and single nucleotide polymorphisms (SNPs) in key genes have been found to modulate the susceptibility of the individuals to the disease. SNPs in 3'-UTR of the target genes or in miRNA seed region has gained much importance as this may lead to impairment of miRNA-mRNA interaction. Not much information about this phenomenon is available with respect to PDAC and we wanted to predict such SNPs which could affect miRNA function in the disease using bioinformatics tools.
After identifying the deregulated miRNAs and genes in PDAC, we determined how many of those altered genes are among experimentally validated targets of those miRNAs. Subsequently, SNPs which could alter these miRNA-mRNA interactions were detected using multiple webtools following high stringent conditions. Disease relevance of the SNPs were also evaluated.
We identified a total of 2492 experimentally validated target genes for 303 miRNAs deregulated in PDAC. Our meta-analysis from 363 PDAC patients and 162 control individuals resulted in a set of differentially expressed genes in pancreatic cancer, which was further compared with the miRNA target genes to get targets differentially expressed in pancreatic cancer. We further detected SNPs either in 'seed' region of miRNAs or 'seed-match' sequence of mRNAs either having disruption or creation of miRNA binding site, correlated the expression for each miRNA-SNP-mRNA interaction. Selected SNPs were found to be in LD with important GWAS identified SNPs.
Our study, hereby, explores the probable effects of SNPs on miRNA-target mRNA interactions. Through stringent analytical methods, we have identified 3 common variants and 13other rare variants possibly interfering with miRNA mediated gene regulation in PDAC.
胰腺导管腺癌 (PDAC) 具有很强的遗传成分,关键基因中的单核苷酸多态性 (SNP) 已被发现可调节个体对疾病的易感性。靶基因 3'UTR 或 miRNA 种子区域中的 SNP 变得非常重要,因为这可能导致 miRNA-mRNA 相互作用受损。关于 PDAC,我们对此现象的了解甚少,我们希望使用生物信息学工具预测可能影响疾病中 miRNA 功能的此类 SNP。
在确定 PDAC 中失调的 miRNA 和基因后,我们确定了这些改变的基因中有多少是这些 miRNA 的实验验证靶基因。随后,使用多种 Web 工具在严格的条件下检测可能改变这些 miRNA-mRNA 相互作用的 SNP。还评估了 SNP 的疾病相关性。
我们总共鉴定了 2492 个实验验证的 303 个 miRNA 在 PDAC 中失调的靶基因。我们对 363 名 PDAC 患者和 162 名对照个体进行的荟萃分析导致了一组在胰腺癌中差异表达的基因,进一步与 miRNA 靶基因进行比较,以获得在胰腺癌中差异表达的靶基因。我们进一步检测了 miRNA 的“种子”区域或 mRNAs 的“种子匹配”序列中的 SNP,这些 SNP 要么破坏要么创建了 miRNA 结合位点,对每个 miRNA-SNP-mRNA 相互作用的表达进行了相关分析。选择的 SNP 与重要的 GWAS 确定的 SNP 存在连锁不平衡。
我们的研究探索了 SNP 对 miRNA 靶基因 mRNA 相互作用的可能影响。通过严格的分析方法,我们确定了 3 个常见变体和 13 个其他可能干扰 PDAC 中 miRNA 介导基因调控的罕见变体。